维生素D代谢物与老年澳大利亚男性肌少症发病的纵向关联
在社区居住的70岁及以上澳大利亚男性中,基线血清25D和1,25D最低四分位组与5年内肌少症发病风险显著升高相关。调整包括相互维生素D指标后关联仍显著,但研究未证明因果关系。
要点
- 基线25D<40nmol/L与5年肌少症发病风险升高相关(OR 2.53)。
- 基线1,25D<62pmol/L与5年肌少症发病风险升高相关(OR 2.67)。
- 两种维生素D代谢物低水平对肌少症发病的关联相互独立。
核心结论
- 基线血清25D和1,25D低浓度与随后5年肌少症发病独立相关。
- 研究数据不能证明因果关系,但维持维生素D充足可能减少老年男性肌少症发病。
研究设计与样本
- 基于Concord Health and Ageing in Men Project的纵向研究,纳入基线无肌少症的70岁及以上社区男性。
- 基线25D分析n=1,312,1,25D分析n=1,231;2年随访分别为1,024和956人;5年随访分别为709和663人。
主要发现
- 2年随访肌少症发病率为3.9%,5年随访为8.6%。
- 5年调整分析中,25D最低四分位组(<40nmol/L)相比最高四分位组肌少症发病OR为2.53(95%CI 1.14, 5.64;p=.02)。
- 5年调整分析中,1,25D最低四分位组(<62pmol/L)相比最高四分位组肌少症发病OR为2.67(95%CI 1.28, 5.60;p=.01)。
- 进一步相互调整后关联仍显著:25D OR 2.40(95%CI 1.02, 5.64;p=.04),1,25D OR 2.23(95%CI 1.04, 4.80;p=.04)。
关键数值与推荐
- 肌少症定义为四肢骨骼肌质量按体重指数调整后<0.789且握力<26.0 kg。
- 血清25D和1,25D采用放射免疫法(Diasorin)于基线测定,并按四分位数分组作为预测变量。
临床怎么用
- 对老年男性可关注基线25D和1,25D水平,低水平者可能属于肌少症高风险人群。
- 维持维生素D充足可能有助于降低老年男性肌少症发病风险,但需进一步研究验证因果。
局限性
- 研究为观察性设计,不能证明因果关系。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To explore the associations between serum 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D) levels at baseline and incidence of sarcopenia over time in older Australian community-dwelling older men. METHODS: Of the 1,705 men aged ≥70 years (2005-2007) participating in the Concord Health and Ageing in Men Project, those without sarcopenia at baseline (n = 1,312 for 25D and n = 1,231 for 1,25D), 2 years (n = 1,024 for 25D and n = 956 for 1,25D), and 5-year follow-up (n = 709 for 25D and n = 663 for 1,25D) were included in the study. The main outcome measurement was the incidence of sarcopenia defined as appendicular lean mass adjusted for body mass index <0.789 and grip strength <26.0 kg. Serum 25D and 1,25D levels were measured at baseline by radioimmunoassay (Diasorin, Stillwater, MN) and categorized into quartiles as predictor variables. Covariates included age, income, season of blood collection, physical activity, vitamin D supplement and medication use, measures of health, serum parathyroid hormone (PTH), estimated glomerular filtration rate (eGFR), albumin, and white blood cell count. RESULTS: In this study, incidence of sarcopenia was 3.9% in men at the 2-year follow-up and 8.6% at the 5-year follow-up. In adjusted analysis, men with vitamin D levels in the lowest quartiles (25D <40nmol/L; 1,25D <62 pmol/L) showed significant associations with increased odds of incident sarcopenia compared to those with vitamin D levels in the highest quartiles over 5 years. [25D: odds ratio (OR) 2.53 (95% confidence interval (CI) 1.14, 5.64) p = .02; 1,25D: OR 2.67 (95% CI 1.28, 5.60) p = .01]. After further adjustments for the respective other serum vitamin D measure, (either 25D or 1,25D), the association remained significant [25D: OR 2.40 (95% CI 1.02, 5.64) p = .04; 1,25D: OR 2.23 (95% CI 1.04, 4.80) p = .04]. CONCLUSION: Low serum 1,25D and 25D concentrations at baseline are independently associated with the incidence of sarcopenia over the subsequent 5 years. Although our data do not prove any causal relationship, it is conceivable that maintaining vitamin D sufficiency may reduce the incidence of sarcopenia in ageing men.
引用
- Hirani V, Cumming RG, Naganathan V, et al. Longitudinal Associations Between Vitamin D Metabolites and Sarcopenia in Older Australian men: The Concord Health and Aging in Men Project. J Gerontol A Biol Sci Med Sci. 2017. PMID: 28549108. doi:10.1093/gerona/glx086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。